Stromelysin-2, also known as matrix metalloproteinase-10 (MMP10), may mediate c-Fos driven cSCC development, and has been linked to lung cancer stem cell maintenance, tumor initiation and metastatic potential [61,62]. The gene discussed is MMP10; the disease is neoplasm.